6-gingerol ameliorated doxorubicin-induced cardiotoxicity: role of nuclear factor kappa B and protein glycation

Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro

(2011) Jing Xiao et al.   TOXICOLOGY

Molecular targets of [6]-gingerol: Its potential roles in cancer chemoprevention

(2010) Ademola A. Oyagbemi et al.   BIOFACTORS

Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes

(2010) Xystus H. L. Tam et al.   CLINICAL SCIENCE

Antioxidant Activities of Celery and Parsley Juices in Rats Treated with Doxorubicin

(2010) Jovanka Kolarovic et al.   MOLECULES

Doxorubicin-Induced Cardiac Toxicity and Cardiac Rest Gated Blood Pool Imaging

(2009) Marta J. Aiken et al.   CLINICAL NUCLEAR MEDICINE

Gastrosplenic Fistula From Hodgkin's Lymphoma

(2009) Carolyn D. Seib et al.   JOURNAL OF CLINICAL ONCOLOGY

Involvement of advanced glycation end-products, pentosidine and Nɛ-(carboxymethyl)lysine, in doxorubicin-induced cardiomyopathy in rats

(2009) Tomoyuki Moriyama et al.   TOXICOLOGY

ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes

(2008) Jiahao Liu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer

(2008) Rade Injac et al.   BIOMATERIALS

Heat Shock Protein 20 Interacting With Phosphorylated Akt Reduces Doxorubicin-Triggered Oxidative Stress and Cardiotoxicity

(2008) Guo-Chang Fan et al.   CIRCULATION RESEARCH

Naringenin Enhances the Anti-Tumor Effect of Doxorubicin Through Selectively Inhibiting the Activity of Multidrug Resistance-Associated Proteins but not P-glycoprotein

(2008) Fa Yun Zhang et al.   PHARMACEUTICAL RESEARCH